Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

Mike Lang, Worldwide President, Circulatory Restoration, MedTech, Johnson & Johnson

“Shockwave C2 Aero Fly is built for the future of coronary interventions, where physicians need proven technologies that can help them move faster without compromising safety or confidence in challenging calcified cases”

Mike Lang, Worldwide President, Circulatory Restoration, MedTech, Johnson & Johnson

“As the pioneer and leader of the category, Johnson & Johnson is giving physicians and patients an increasingly efficient, predictable platform designed to meet the growing demands of complex coronary care.”

Hector Tamez Aguilar, M.D., Interventional Cardiologist at Piedmont Healthcare in Atlanta, Georgia

“In the cath lab, every second matters, especially as we see more complex cases and higher procedure volumes”

Hector Tamez Aguilar, M.D., Interventional Cardiologist at Piedmont Healthcare in Atlanta, Georgia

“By delivering pulses twice as fast and decreasing pause time between cycles, Shockwave C2 Aero Fly enables faster workflows, helping physicians treat calcified coronary disease more efficiently while meeting the growing pace and demand of cath labs.”

Karim Al-Azizi, M.D., Medical Director, Structural Heart Program and Cardiac Catheterization Laboratories at Baylor Scott & White Health, Plano, Texas

“During IVL treatment, balloon inflation temporarily blocks blood flow, and that time matters for patient care”

Karim Al-Azizi, M.D., Medical Director, Structural Heart Program and Cardiac Catheterization Laboratories at Baylor Scott & White Health, Plano, Texas

“Shockwave C2 Aero Fly raises the bar for coronary interventions by making procedures easier for physicians and less strenuous for patients. Its shorter balloon inflation and pause time reduce ischemic time and related symptoms for patients, enabling better, quicker and more streamlined care.”